Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
Additional Paid-In Capital
$3,371.4 Mil (As of Sep. 2015)

Biomarin Pharmaceutical Inc's quarterly additional paid-in capital increased from Mar. 2015 ($3,308.1 Mil) to Jun. 2015 ($3,337.5 Mil) and increased from Jun. 2015 ($3,337.5 Mil) to Sep. 2015 ($3,371.4 Mil).

Biomarin Pharmaceutical Inc's annual additional paid-in capital increased from Dec. 2012 ($1,561.9 Mil) to Dec. 2013 ($2,059.1 Mil) and increased from Dec. 2013 ($2,059.1 Mil) to Dec. 2014 ($2,359.7 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical Inc Annual Data

AdditionalPaidInCapital 485.6709.4794.9852.9900.01,090.21,197.11,561.92,059.12,359.7

Biomarin Pharmaceutical Inc Quarterly Data

AdditionalPaidInCapital 1,864.01,926.12,059.12,213.32,249.42,278.82,359.73,308.13,337.53,371.4
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership